253 related articles for article (PubMed ID: 22240810)
1. Deletion of CaMKK2 from the liver lowers blood glucose and improves whole-body glucose tolerance in the mouse.
Anderson KA; Lin F; Ribar TJ; Stevens RD; Muehlbauer MJ; Newgard CB; Means AR
Mol Endocrinol; 2012 Feb; 26(2):281-91. PubMed ID: 22240810
[TBL] [Abstract][Full Text] [Related]
2. Calcium/calmodulin-dependent protein kinase kinase 2 regulates macrophage-mediated inflammatory responses.
Racioppi L; Noeldner PK; Lin F; Arvai S; Means AR
J Biol Chem; 2012 Mar; 287(14):11579-91. PubMed ID: 22334678
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1α deficiency reduces adiposity, glucose intolerance and hepatic de-novo lipogenesis in diet-induced obese mice.
Almog T; Kandel Kfir M; Levkovich H; Shlomai G; Barshack I; Stienstra R; Lustig Y; Leikin Frenkel A; Harari A; Bujanover Y; Apte R; Shaish A; Harats D; Kamari Y
BMJ Open Diabetes Res Care; 2019; 7(1):e000650. PubMed ID: 31749969
[TBL] [Abstract][Full Text] [Related]
4. Research Resource: Roles for Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) in Systems Metabolism.
Marcelo KL; Ribar T; Means CR; Tsimelzon A; Stevens RD; Ilkayeva O; Bain JR; Hilsenbeck SG; Newgard CB; Means AR; York B
Mol Endocrinol; 2016 May; 30(5):557-72. PubMed ID: 27003444
[TBL] [Abstract][Full Text] [Related]
5. Enhanced susceptibility of Cpt1c knockout mice to glucose intolerance induced by a high-fat diet involves elevated hepatic gluconeogenesis and decreased skeletal muscle glucose uptake.
Gao XF; Chen W; Kong XP; Xu AM; Wang ZG; Sweeney G; Wu D
Diabetologia; 2009 May; 52(5):912-20. PubMed ID: 19224198
[TBL] [Abstract][Full Text] [Related]
6. Calcium/calmodulin-dependent protein kinase kinase 2 regulates hepatic fuel metabolism.
Stork BA; Dean A; Ortiz AR; Saha P; Putluri N; Planas-Silva MD; Mahmud I; Rajapakshe K; Coarfa C; Knapp S; Lorenzi PL; Kemp BE; Turk BE; Scott JW; Means AR; York B
Mol Metab; 2022 Aug; 62():101513. PubMed ID: 35562082
[TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity.
Nixon M; Stewart-Fitzgibbon R; Fu J; Akhmedov D; Rajendran K; Mendoza-Rodriguez MG; Rivera-Molina YA; Gibson M; Berglund ED; Justice NJ; Berdeaux R
Mol Metab; 2016 Jan; 5(1):34-46. PubMed ID: 26844205
[TBL] [Abstract][Full Text] [Related]
8. Hepatic extracellular signal-regulated kinase 2 suppresses endoplasmic reticulum stress and protects from oxidative stress and endothelial dysfunction.
Kujiraoka T; Satoh Y; Ayaori M; Shiraishi Y; Arai-Nakaya Y; Hakuno D; Yada H; Kuwada N; Endo S; Isoda K; Adachi T
J Am Heart Assoc; 2013 Aug; 2(4):e000361. PubMed ID: 23954796
[TBL] [Abstract][Full Text] [Related]
9. Hemin Improves Insulin Sensitivity and Lipid Metabolism in Cultured Hepatocytes and Mice Fed a High-Fat Diet.
Luan Y; Zhang F; Cheng Y; Liu J; Huang R; Yan M; Wang Y; He Z; Lai H; Wang H; Ying H; Guo F; Zhai Q
Nutrients; 2017 Jul; 9(8):. PubMed ID: 28933767
[TBL] [Abstract][Full Text] [Related]
10. Elevated tissue omega-3 fatty acid status prevents age-related glucose intolerance in fat-1 transgenic mice.
Romanatto T; Fiamoncini J; Wang B; Curi R; Kang JX
Biochim Biophys Acta; 2014 Feb; 1842(2):186-91. PubMed ID: 24211484
[TBL] [Abstract][Full Text] [Related]
11. Loss of CTRP1 disrupts glucose and lipid homeostasis.
Rodriguez S; Lei X; Petersen PS; Tan SY; Little HC; Wong GW
Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E678-E697. PubMed ID: 27555298
[TBL] [Abstract][Full Text] [Related]
12. Gluconeogenic signals regulate iron homeostasis via hepcidin in mice.
Vecchi C; Montosi G; Garuti C; Corradini E; Sabelli M; Canali S; Pietrangelo A
Gastroenterology; 2014 Apr; 146(4):1060-9. PubMed ID: 24361124
[TBL] [Abstract][Full Text] [Related]
13. PKCλ haploinsufficiency prevents diabetes by a mechanism involving alterations in hepatic enzymes.
Sajan MP; Ivey RA; Lee M; Mastorides S; Jurczak MJ; Samuels VT; Shulman GI; Braun U; Leitges M; Farese RV
Mol Endocrinol; 2014 Jul; 28(7):1097-107. PubMed ID: 24877563
[TBL] [Abstract][Full Text] [Related]
14. Differentially regulated protein kinase A (PKA) activity in adipose tissue and liver is associated with resistance to diet-induced obesity and glucose intolerance in mice that lack PKA regulatory subunit type IIα.
London E; Nesterova M; Sinaii N; Szarek E; Chanturiya T; Mastroyannis SA; Gavrilova O; Stratakis CA
Endocrinology; 2014 Sep; 155(9):3397-408. PubMed ID: 24914943
[TBL] [Abstract][Full Text] [Related]
15. Acetyl-CoA carboxylase 2-/- mutant mice are protected against fatty liver under high-fat, high-carbohydrate dietary and de novo lipogenic conditions.
Abu-Elheiga L; Wu H; Gu Z; Bressler R; Wakil SJ
J Biol Chem; 2012 Apr; 287(15):12578-88. PubMed ID: 22362781
[TBL] [Abstract][Full Text] [Related]
16. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice.
Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J
Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin inhibits gluconeogenesis and inflammation in the liver and improves glucose intolerance in high-fat diet-fed mice.
Meng R; Zhu D; Bi Y; Yang D; Wang Y
PLoS One; 2013; 8(1):e53557. PubMed ID: 23326455
[TBL] [Abstract][Full Text] [Related]
18. β Cell-specific deletion of guanylyl cyclase A, the receptor for atrial natriuretic peptide, accelerates obesity-induced glucose intolerance in mice.
Tauscher S; Nakagawa H; Völker K; Werner F; Krebes L; Potapenko T; Doose S; Birkenfeld AL; Baba HA; Kuhn M
Cardiovasc Diabetol; 2018 Jul; 17(1):103. PubMed ID: 30016962
[TBL] [Abstract][Full Text] [Related]
19. [Deletion of CD36 gene ameliorates glucose metabolism abnormality induced by high-fat diet and promotes liver lipid accumulation].
Luo XQ; Zeng H; Tan W; Yang P; Chen YX; Ruan XZ
Sheng Li Xue Bao; 2021 Oct; 73(5):805-812. PubMed ID: 34708237
[TBL] [Abstract][Full Text] [Related]
20. Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet.
Wada T; Kenmochi H; Miyashita Y; Sasaki M; Ojima M; Sasahara M; Koya D; Tsuneki H; Sasaoka T
Endocrinology; 2010 May; 151(5):2040-9. PubMed ID: 20211973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
